These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3959968)

  • 21. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buprenorphine withdrawal syndrome in a newborn.
    Marquet P; Chevrel J; Lavignasse P; Merle L; Lachâtre G
    Clin Pharmacol Ther; 1997 Nov; 62(5):569-71. PubMed ID: 9390114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial of one-day vs. three-day buprenorphine inpatient detoxification protocols for heroin dependence.
    Hopper JA; Wu J; Martus W; Pierre JD
    J Opioid Manag; 2005; 1(1):31-5. PubMed ID: 17315409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buprenorphine in opiate withdrawal: a comparison with clonidine.
    Nigam AK; Ray R; Tripathi BM
    J Subst Abuse Treat; 1993; 10(4):391-4. PubMed ID: 8257551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence.
    White J; Bell J; Saunders JB; Williamson P; Makowska M; Farquharson A; Beebe KL
    Drug Alcohol Depend; 2009 Jul; 103(1-2):37-43. PubMed ID: 19403243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buprenorphine as new treatment for heroin dependence.
    Reisinger M
    Drug Alcohol Depend; 1985 Dec; 16(3):257-62. PubMed ID: 4092611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A randomized, double-blind, controlled study: Ji-Tai tablet for the treatment of acute withdrawl syndrome of mild heroin dependence].
    Wang Y; Tang C; Cheng S; Cui G; Zhang R; Zhang Z; Xie L; Lin Y; Hao W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Feb; 40(2):117-22. PubMed ID: 25769319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
    Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence.
    Montoya ID; Gorelick DA; Preston KL; Schroeder JR; Umbricht A; Cheskin LJ; Lange WR; Contoreggi C; Johnson RE; Fudala PJ
    Clin Pharmacol Ther; 2004 Jan; 75(1):34-48. PubMed ID: 14749690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buprenorphine maintenance treatment of heroin dependence: the first experience from Iran.
    Ahmadi J
    J Subst Abuse Treat; 2002 Apr; 22(3):157-9. PubMed ID: 12039619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid detoxification of heroin dependence by buprenorphine.
    Liu ZM; Cai ZJ; Wang XP; Ge Y; Li CM
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):112-4. PubMed ID: 10072959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence.
    Rothman RB; Gorelick DA; Heishman SJ; Eichmiller PR; Hill BH; Norbeck J; Liberto JG
    J Subst Abuse Treat; 2000 Apr; 18(3):277-81. PubMed ID: 10742642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED; Kleber HD; Whittington RA; Heitler NE
    JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment.
    Giacomuzzi SM; Ertl M; Kemmler G; Riemer Y; Vigl A
    ScientificWorldJournal; 2005 May; 5():452-68. PubMed ID: 15925962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period.
    Correia CJ; Walsh SL; Bigelow GE; Strain EC
    Psychopharmacology (Berl); 2006 Dec; 189(3):297-306. PubMed ID: 17013637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
    Blennow G; Fergusson A; Medvedeo A
    Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buprenorphine: an alternative to methadone for heroin dependence treatment.
    Resnick RB; Galanter M; Pycha C; Cohen A; Grandison P; Flood N
    Psychopharmacol Bull; 1992; 28(1):109-13. PubMed ID: 1609035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Buprenorphine as maintenance treatment in rehabilitation of heroin addicts].
    Bramness JG; Bachs LC; Waal H
    Tidsskr Nor Laegeforen; 2002 Oct; 122(25):2452-4. PubMed ID: 12448114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals.
    Amass L; Pukeleviciene V; Subata E; Almeida AR; Pieri MC; D'Egidio P; Stankova Z; Costa A; Smyth BP; Sakoman S; Wei Y; Strang J
    Addiction; 2012 Jan; 107(1):142-51. PubMed ID: 21749526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.